Begin main content

Infliximab

Published on: May 30, 2014
Result type: Reports
Project Number: SE0383-000
Product Line: Common Drug Review

Generic Name: Infliximab

Brand Name: Remsima

Manufacturer: Fresenius Kabi Canada

Indications: Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis

Submission Type: New

Project Status: Withdrawn

Call For Patient Input: July 15, 2014

Patient Input Closed: September 4, 2014

Subsequent Entry Biologic: Yes

Date Submission Received: May 30, 2014

Tags

arthritis, psoriatic, arthritis, rheumatoid, biosimilar pharmaceuticals, psoriasis, spondylitis, ankylosing, dermatology, musculoskeletal